US7354713B2 - Method of Using Estrogen-Related Receptor Gamma (ERRγ) Status to Determine Prognosis and Treatment Strategy for Breast Cancer, Method of Using ERRγ as a Therapeutic Target for Treating Breast Cancer, Method of Using ERRγ to Diagnose Breast Cancer, and Method of Using ERRγ to Identify Individuals Predisposed to Breast Cancer | Patent Bear